The experience of sibutramine administration in patients with obesity and controlled arterial hypertension

The experience of sibutramine administration in patients with obesity and controlled arterial hypertension

BACKGROUND: Obesity is a metabolic disorder that becomes epidemic. Visceral adiposity increases the risk of arterial hypertension, diabetes mellitus and other comorbidities. According to this, the main aim of obesity treatment is not only a weight loss but also a decrease of the risk of comorbiditie...

Full description

Bibliographic Details
Main Authors: Elena Y. Shupenina, Elena N. Yushchuk, Yury A. Vasyuk, Svetlana V. Yureneva, Anastasia V. Dubrovina
Format: Article
Language:English
Published: Endocrinology Research Centre 2019-09-01
Series:Ожирение и метаболизм
Subjects:
visceral adiposity
arterial hypertension
epicardial fat
sibutramine
Online Access:https://omet-endojournals.ru/omet/article/viewFile/9789/7845

Similar Items

Similar Items